Eric Littmann

Title: Eric Littmann: Innovator in CAR T Cell Therapy

Introduction

Eric Littmann is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of cancer treatment, particularly in the area of CAR T cell therapy. His innovative work focuses on improving patient outcomes through advanced methodologies.

Latest Patents

Eric Littmann holds a patent titled "Methods and compositions for identifying and treating subjects at risk for poor CAR T cell therapy response." This invention relates to compositions, methods, and kits for predicting a subject's response to CAR T cell therapy by analyzing the intestinal microbiome. The patent also provides a method for detecting patients at risk for a poor response to CAR T cell therapy by measuring specific bacteria or bacterial genes in the patient's microflora. Furthermore, it offers therapeutic compositions and methods aimed at enhancing a subject's response to CAR T cell therapy.

Career Highlights

Eric Littmann is affiliated with Memorial Sloan Kettering Cancer Center, where he continues to advance research in cancer therapies. His work is pivotal in understanding how microbiome analysis can influence treatment efficacy.

Collaborations

Some of his notable coworkers include Melody Smith and Marcel Van Den Brink, who contribute to the collaborative efforts in cancer research and therapy development.

Conclusion

Eric Littmann's innovative approach to CAR T cell therapy exemplifies the intersection of microbiome research and cancer treatment. His contributions are vital for improving patient care and outcomes in oncology.